NRAS Gene Mutation
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| NAUTILUS: OKI-179 Plus Binimetinib in Patients with Advanced Solid Tumors in the RAS Pathway (Phase 1b) and NRAS-mutated Melanoma (Phase 2) (NCT05340621) | OnKure, Inc. | 2022-05-11 |
| OPTImal PALliative Anti-epidermal Growth Factor Receptor Treatment in Metastatic Colorectal Cancer - (NCT03750175) | Karen-Lise Garm Spindler | 2018-06-01 |
Track NRAS Gene Mutation automatically
Every clearance here is in the API, with alerts when new ones post.